Rakesh Karmacharya, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Induced Pluripotent Stem Cells | 13 | 2023 | 1890 | 2.720 |
Why?
|
Neural Stem Cells | 5 | 2020 | 892 | 1.490 |
Why?
|
Schizophrenia | 11 | 2023 | 6986 | 1.450 |
Why?
|
Organoids | 3 | 2020 | 749 | 1.350 |
Why?
|
Neurons | 7 | 2023 | 9504 | 0.930 |
Why?
|
Clozapine | 4 | 2011 | 508 | 0.780 |
Why?
|
Bipolar Disorder | 6 | 2020 | 5124 | 0.680 |
Why?
|
Cerebrum | 1 | 2020 | 132 | 0.640 |
Why?
|
Electrophysiological Phenomena | 1 | 2020 | 309 | 0.610 |
Why?
|
Acetylcysteine | 1 | 2019 | 262 | 0.610 |
Why?
|
Cell Culture Techniques | 2 | 2016 | 1669 | 0.610 |
Why?
|
Psychotic Disorders | 5 | 2024 | 3278 | 0.610 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2019 | 264 | 0.600 |
Why?
|
Plasmalogens | 1 | 2016 | 30 | 0.560 |
Why?
|
Neuronal Plasticity | 2 | 2023 | 1448 | 0.550 |
Why?
|
Prisoners | 1 | 2020 | 317 | 0.550 |
Why?
|
Regenerative Medicine | 1 | 2020 | 311 | 0.540 |
Why?
|
Interferon-gamma | 2 | 2022 | 3169 | 0.530 |
Why?
|
Synapses | 3 | 2023 | 1766 | 0.530 |
Why?
|
Cerebral Cortex | 3 | 2023 | 5827 | 0.510 |
Why?
|
Lysine | 2 | 2017 | 989 | 0.500 |
Why?
|
Cryopreservation | 1 | 2020 | 731 | 0.500 |
Why?
|
Phosphatidylcholines | 1 | 2016 | 406 | 0.490 |
Why?
|
Interneurons | 1 | 2019 | 592 | 0.480 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9507 | 0.460 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2019 | 776 | 0.450 |
Why?
|
beta Catenin | 2 | 2015 | 1048 | 0.390 |
Why?
|
Interleukin-6 | 1 | 2022 | 3234 | 0.390 |
Why?
|
Antipsychotic Agents | 6 | 2016 | 3077 | 0.390 |
Why?
|
Antioxidants | 1 | 2019 | 1678 | 0.380 |
Why?
|
Endothelial Cells | 2 | 2023 | 3586 | 0.380 |
Why?
|
Caenorhabditis elegans | 2 | 2011 | 1462 | 0.360 |
Why?
|
Cells, Cultured | 7 | 2023 | 19041 | 0.360 |
Why?
|
Histone Deacetylases | 1 | 2015 | 717 | 0.350 |
Why?
|
Nerve Tissue Proteins | 2 | 2020 | 4417 | 0.340 |
Why?
|
Cell Differentiation | 7 | 2022 | 11674 | 0.340 |
Why?
|
Meditation | 1 | 2013 | 257 | 0.340 |
Why?
|
Metabolome | 1 | 2016 | 1009 | 0.330 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 960 | 0.330 |
Why?
|
Mental Health Services | 2 | 2020 | 1732 | 0.330 |
Why?
|
Stress, Physiological | 1 | 2016 | 1409 | 0.320 |
Why?
|
Awareness | 1 | 2013 | 654 | 0.320 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2465 | 0.310 |
Why?
|
Indoles | 1 | 2016 | 1834 | 0.300 |
Why?
|
Stem Cells | 2 | 2023 | 3538 | 0.300 |
Why?
|
Catatonia | 1 | 2011 | 181 | 0.290 |
Why?
|
Coculture Techniques | 2 | 2021 | 1343 | 0.280 |
Why?
|
Brain Diseases | 1 | 2016 | 1553 | 0.270 |
Why?
|
Mitochondria | 1 | 2020 | 3672 | 0.270 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 1969 | 0.270 |
Why?
|
Gene Expression | 2 | 2016 | 7605 | 0.270 |
Why?
|
Electroconvulsive Therapy | 2 | 2011 | 502 | 0.260 |
Why?
|
Fibroblasts | 1 | 2016 | 4180 | 0.260 |
Why?
|
Protein Isoforms | 2 | 2023 | 1706 | 0.260 |
Why?
|
Blood-Brain Barrier | 2 | 2023 | 1034 | 0.250 |
Why?
|
Cell Membrane | 1 | 2015 | 3664 | 0.250 |
Why?
|
Acetylation | 2 | 2017 | 1053 | 0.220 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2023 | 146 | 0.210 |
Why?
|
Behavior, Animal | 1 | 2011 | 1882 | 0.210 |
Why?
|
Models, Biological | 3 | 2016 | 9505 | 0.210 |
Why?
|
Brain | 3 | 2023 | 27438 | 0.210 |
Why?
|
Attention | 1 | 2013 | 2423 | 0.210 |
Why?
|
Varicose Veins | 1 | 2023 | 157 | 0.190 |
Why?
|
Humans | 36 | 2024 | 768451 | 0.190 |
Why?
|
Microglia | 2 | 2021 | 1376 | 0.190 |
Why?
|
Nerve Net | 1 | 2013 | 2362 | 0.180 |
Why?
|
Signal Transduction | 7 | 2020 | 23638 | 0.180 |
Why?
|
Neurocan | 1 | 2020 | 21 | 0.180 |
Why?
|
Eosinophilia | 1 | 2005 | 558 | 0.180 |
Why?
|
Collagen Type IV | 1 | 2020 | 125 | 0.170 |
Why?
|
Mental Disorders | 2 | 2020 | 6879 | 0.170 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2020 | 142 | 0.170 |
Why?
|
Basement Membrane | 1 | 2020 | 349 | 0.170 |
Why?
|
Appendectomy | 1 | 2023 | 442 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2884 | 0.160 |
Why?
|
Microelectrodes | 1 | 2020 | 308 | 0.160 |
Why?
|
International Classification of Diseases | 1 | 2024 | 925 | 0.160 |
Why?
|
Fibronectins | 1 | 2020 | 725 | 0.140 |
Why?
|
Membrane Potentials | 1 | 2020 | 1090 | 0.140 |
Why?
|
Lectins, C-Type | 1 | 2020 | 589 | 0.140 |
Why?
|
Colitis | 1 | 2005 | 1244 | 0.140 |
Why?
|
Discriminant Analysis | 1 | 2016 | 224 | 0.130 |
Why?
|
Appendicitis | 1 | 2023 | 687 | 0.130 |
Why?
|
Electric Impedance | 1 | 2020 | 796 | 0.130 |
Why?
|
Least-Squares Analysis | 1 | 2016 | 368 | 0.130 |
Why?
|
Delirium | 1 | 2008 | 1694 | 0.130 |
Why?
|
Mice, Knockout | 1 | 2011 | 14480 | 0.130 |
Why?
|
Lymphocytes | 1 | 2023 | 2611 | 0.120 |
Why?
|
Neurotoxins | 1 | 2016 | 241 | 0.120 |
Why?
|
Pluripotent Stem Cells | 1 | 2022 | 808 | 0.120 |
Why?
|
Folic Acid | 1 | 2022 | 1336 | 0.120 |
Why?
|
Membrane Transport Proteins | 1 | 2020 | 1036 | 0.120 |
Why?
|
Cell Line, Transformed | 1 | 2016 | 868 | 0.120 |
Why?
|
Culture Media | 1 | 2016 | 899 | 0.120 |
Why?
|
Insulin | 1 | 2009 | 6606 | 0.120 |
Why?
|
Buddhism | 1 | 2013 | 23 | 0.110 |
Why?
|
Cell Adhesion | 1 | 2020 | 3103 | 0.110 |
Why?
|
Neovascularization, Physiologic | 1 | 2020 | 1369 | 0.110 |
Why?
|
Fetus | 1 | 2020 | 1883 | 0.110 |
Why?
|
Molecular Structure | 1 | 2017 | 1889 | 0.100 |
Why?
|
Extracellular Matrix | 1 | 2020 | 1738 | 0.100 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2016 | 664 | 0.100 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12774 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2039 | 0.100 |
Why?
|
Nepal | 2 | 2023 | 301 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4362 | 0.100 |
Why?
|
Protein Structure, Secondary | 1 | 2015 | 1223 | 0.100 |
Why?
|
Oviposition | 1 | 2011 | 22 | 0.090 |
Why?
|
Biogenic Amines | 1 | 2011 | 53 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2017 | 3594 | 0.090 |
Why?
|
Religion and Psychology | 1 | 2013 | 180 | 0.090 |
Why?
|
Depression | 3 | 2021 | 8235 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2023 | 3484 | 0.090 |
Why?
|
Riluzole | 1 | 2010 | 61 | 0.090 |
Why?
|
Case-Control Studies | 2 | 2020 | 22293 | 0.090 |
Why?
|
Neutrophils | 1 | 2023 | 3790 | 0.090 |
Why?
|
Adult | 12 | 2024 | 223542 | 0.090 |
Why?
|
Isoenzymes | 1 | 2015 | 1685 | 0.090 |
Why?
|
Ubiquitination | 1 | 2015 | 1010 | 0.090 |
Why?
|
Prefrontal Cortex | 1 | 2020 | 2251 | 0.080 |
Why?
|
Structure-Activity Relationship | 1 | 2015 | 3073 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3612 | 0.080 |
Why?
|
Drug Discovery | 1 | 2017 | 1062 | 0.080 |
Why?
|
Dexamethasone | 1 | 2016 | 1965 | 0.080 |
Why?
|
Genes, Reporter | 2 | 2010 | 1525 | 0.080 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2015 | 1322 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3790 | 0.070 |
Why?
|
Growth Inhibitors | 1 | 2009 | 375 | 0.070 |
Why?
|
Animals | 7 | 2023 | 169418 | 0.070 |
Why?
|
Melanoma, Experimental | 1 | 2010 | 561 | 0.070 |
Why?
|
Larva | 1 | 2009 | 514 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2016 | 2170 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4877 | 0.070 |
Why?
|
Kinetics | 1 | 2015 | 6348 | 0.070 |
Why?
|
Cytokines | 1 | 2022 | 7449 | 0.070 |
Why?
|
Mental Recall | 1 | 2013 | 1226 | 0.070 |
Why?
|
Species Specificity | 1 | 2011 | 2422 | 0.070 |
Why?
|
Middle Aged | 9 | 2024 | 223418 | 0.070 |
Why?
|
Wnt Proteins | 1 | 2010 | 724 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2020 | 10494 | 0.070 |
Why?
|
Pharynx | 1 | 2009 | 436 | 0.070 |
Why?
|
Hippocampus | 1 | 2019 | 3783 | 0.070 |
Why?
|
Cell Survival | 1 | 2016 | 5801 | 0.070 |
Why?
|
Binding Sites | 1 | 2015 | 6030 | 0.060 |
Why?
|
Male | 11 | 2024 | 364781 | 0.060 |
Why?
|
Mental Health | 1 | 2020 | 3271 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2009 | 1164 | 0.060 |
Why?
|
Models, Molecular | 2 | 2015 | 5443 | 0.060 |
Why?
|
Receptor, Insulin | 1 | 2009 | 838 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4355 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2015 | 2780 | 0.060 |
Why?
|
Executive Function | 1 | 2013 | 1402 | 0.060 |
Why?
|
Blood Sedimentation | 1 | 2005 | 235 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10784 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11930 | 0.060 |
Why?
|
Phosphorylation | 1 | 2015 | 8332 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2011 | 1254 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2072 | 0.050 |
Why?
|
Female | 9 | 2024 | 396943 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4816 | 0.050 |
Why?
|
Adolescent | 8 | 2023 | 89168 | 0.050 |
Why?
|
Models, Animal | 1 | 2009 | 2126 | 0.050 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2009 | 875 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2011 | 4294 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1625 | 0.050 |
Why?
|
Hospitals, University | 1 | 2023 | 569 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2023 | 793 | 0.050 |
Why?
|
Evolution, Molecular | 1 | 2009 | 1897 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2023 | 65409 | 0.040 |
Why?
|
Saphenous Vein | 1 | 2023 | 519 | 0.040 |
Why?
|
Young Adult | 6 | 2024 | 60045 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2023 | 1604 | 0.040 |
Why?
|
Mice | 3 | 2017 | 82045 | 0.040 |
Why?
|
Lithium Compounds | 1 | 2020 | 226 | 0.040 |
Why?
|
Diarrhea | 1 | 2005 | 1320 | 0.040 |
Why?
|
Minocycline | 1 | 2019 | 170 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16712 | 0.040 |
Why?
|
Fever | 1 | 2005 | 1622 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 24311 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2023 | 81834 | 0.030 |
Why?
|
Antimanic Agents | 1 | 2020 | 524 | 0.030 |
Why?
|
Developed Countries | 1 | 2019 | 451 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8559 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26351 | 0.030 |
Why?
|
Social Work | 1 | 2015 | 158 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2019 | 1196 | 0.030 |
Why?
|
Patient Dropouts | 1 | 2015 | 411 | 0.030 |
Why?
|
Social Adjustment | 1 | 2015 | 636 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 13026 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22365 | 0.030 |
Why?
|
United States | 1 | 2020 | 73121 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2020 | 1923 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3906 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2008 | 15965 | 0.020 |
Why?
|
Transcription Factors | 1 | 2009 | 12174 | 0.020 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2010 | 195 | 0.020 |
Why?
|
Skin Pigmentation | 1 | 2010 | 278 | 0.020 |
Why?
|
Risk Factors | 3 | 2021 | 74915 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13708 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54914 | 0.020 |
Why?
|
Developing Countries | 1 | 2019 | 2901 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20231 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7863 | 0.020 |
Why?
|
Patient Care Team | 1 | 2015 | 2526 | 0.010 |
Why?
|
Algorithms | 1 | 2024 | 14158 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8908 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2832 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3437 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10601 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42623 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7471 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2015 | 4453 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1991 | 4213 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1991 | 4948 | 0.010 |
Why?
|
Aged | 2 | 2023 | 171520 | 0.010 |
Why?
|
Child | 1 | 2023 | 80863 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39430 | 0.010 |
Why?
|
Polyenes | 1 | 1991 | 68 | 0.010 |
Why?
|
Molecular Conformation | 1 | 1991 | 542 | 0.010 |
Why?
|
Exocytosis | 1 | 1991 | 323 | 0.010 |
Why?
|
Cyclosporine | 1 | 1991 | 780 | 0.000 |
Why?
|
Tacrolimus | 1 | 1991 | 750 | 0.000 |
Why?
|
Ligands | 1 | 1991 | 3281 | 0.000 |
Why?
|
Sirolimus | 1 | 1991 | 1542 | 0.000 |
Why?
|
Cell Division | 1 | 1991 | 4479 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1991 | 7599 | 0.000 |
Why?
|